Analytical Data
-
Gene name
KGF-2/FGF-10
- Application
-
Alternative Names
FGF-10,
-
Species
Human
-
Source
E. coli
-
Tag
Tag Free
-
Purity
Greater than 97% as determined by SDS-PAGE.
-
Uniprot
O15520
-
Expression Region
40-208aa
-
Protein Length
Partial
-
Molecular Weight
19.1 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
KGF-2 (Keratinocyte Growth Factor-2) and FGF-10 (Fibroblast Growth Factor-10) are members of the FGF family that play critical roles in various biological processes, including cell proliferation, differentiation, and tissue repair. These growth factors are particularly important in epithelial and mesenchymal interactions, influencing skin, lung, and gastrointestinal development. KGF-2 has been shown to stimulate keratinocyte proliferation and migration, making it vital for wound healing and tissue regeneration. FGF-10, on the other hand, is involved in the development of multiple organ systems and is essential for maintaining epithelial integrity. Recent studies have highlighted the therapeutic potential of KGF-2/FGF-10 recombinant proteins in regenerative medicine, particularly in treatments for skin injuries, respiratory diseases, and gastrointestinal disorders. Their ability to enhance cellular responses and promote healing mechanisms makes them promising candidates for developing novel therapies. The ongoing research focuses on optimizing the production methods of these recombinant proteins and elucidating their mechanisms of action, which could lead to advanced treatment options for a variety of conditions characterized by tissue damage or impaired regeneration. Understanding the synergistic effects of KGF-2 and FGF-10 in tissue repair could pave the way for innovative regenerative strategies that leverage their unique biological properties to improve patient outcomes.
